ZimVie Makes Strides in Right-Sizing Business

ZimVie reported 2Q22 orthopedic sales of $115.2 million, -19.6% compared to 2Q21.

The company exited some unprofitable markets in 2021, discontinued some products as part of a brand rationalization effort and is still untangling itself from Zimmer Biomet in certain markets. Adjusting for these factors, ZimVie's spine sales declined -13.2%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us